chr14-75633695-C-T
Variant summary
Our verdict is Uncertain significance. Variant got 2 ACMG points: 3P and 1B. PM2PP3BS1_Supporting
The NM_017791.3(FLVCR2):c.1019C>T(p.Pro340Leu) variant causes a missense, splice region change. The variant allele was found at a frequency of 0.0000298 in 1,611,190 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. 2/3 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Uncertain significance (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. P340T) has been classified as Uncertain significance.
Frequency
Consequence
NM_017791.3 missense, splice_region
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
FLVCR2 | NM_017791.3 | c.1019C>T | p.Pro340Leu | missense_variant, splice_region_variant | 4/10 | ENST00000238667.9 | |
FLVCR2 | NM_001195283.2 | c.404C>T | p.Pro135Leu | missense_variant, splice_region_variant | 4/10 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
FLVCR2 | ENST00000238667.9 | c.1019C>T | p.Pro340Leu | missense_variant, splice_region_variant | 4/10 | 1 | NM_017791.3 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000329 AC: 5AN: 152194Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000915 AC: 23AN: 251424Hom.: 0 AF XY: 0.0000809 AC XY: 11AN XY: 135888
GnomAD4 exome AF: 0.0000295 AC: 43AN: 1458996Hom.: 0 Cov.: 30 AF XY: 0.0000275 AC XY: 20AN XY: 726112
GnomAD4 genome AF: 0.0000329 AC: 5AN: 152194Hom.: 0 Cov.: 32 AF XY: 0.0000404 AC XY: 3AN XY: 74344
ClinVar
Submissions by phenotype
FLVCR2-related disorder Uncertain:1
Uncertain significance, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | May 17, 2024 | The FLVCR2 c.1019C>T variant is predicted to result in the amino acid substitution p.Pro340Leu. This variant has been reported in the compound heterozygous state in an individual with Fowler syndrome (Kalailingam et al. 2020. PubMed ID: 32369449). This variant is reported in 0.043% of alleles in individuals of Latino descent in gnomAD. At this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. - |
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jul 14, 2022 | This sequence change replaces proline, which is neutral and non-polar, with leucine, which is neutral and non-polar, at codon 340 of the FLVCR2 protein (p.Pro340Leu). This variant is present in population databases (rs750773606, gnomAD 0.04%). This missense change has been observed in individual(s) with Fowler syndrome (PMID: 32369449). ClinVar contains an entry for this variant (Variation ID: 1032766). Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be disruptive. Studies have shown that this missense change does not significantly alter or has an unclear effect on FLVCR2 gene expression (PMID: 32369449). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
Fowler syndrome Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Baylor Genetics | Aug 14, 2018 | This variant was determined to be of uncertain significance according to ACMG Guidelines, 2015 [PMID:25741868]. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at